POSA28 Reductions in Migraine and Headache Days After Initiating Fremanezumab for Patients with Migraine and Prior Use of Another Monoclonal Antibody Targeting the CGRP Pathway in a US Real-World Setting
Abstract
Authors
M Driessen O Patterson-Lomba F Mu S Thompson M Seminerio K Carr R Sun T Totev E Yim R Ayyagari J Cohen